CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

Home・Akciju saraksts・CryoPort Inc

CryoPort Inc

Slēgts

SektorsRūpniecība

13.24 1.53

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.96

Max

13.46

Galvenie mērījumi
By Trading Economics
Ienākumi	14M -9.4M
Pārdošana	2.3M 48M
EPS	-0.189
Peļņas marža	-19.733
Darbinieki	684
EBITDA	443K -3.2M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+4.14% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 4. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	143M 664M
Iepriekšējā atvēršanas cena	11.71
Iepriekšējā slēgšanas cena	13.24

Ziņu noskaņojums

By Acuity

94%

386 / 405 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

5.615 / N/A Atbalsts un pretestība

CryoPort Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. maijs 22:54 UTC

Peļņas

Xero Lifts Annual Earnings 18%, Flags More Growth Ahead

2026. g. 13. maijs 23:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 13. maijs 23:51 UTC

Tirgus saruna

Australian Consumer Spending Is Holding Up; RBA Watching -- Market Talk

2026. g. 13. maijs 23:45 UTC

Tirgus saruna

Nikkei May Rise After Overnight U.S. Tech Gains -- Market Talk

2026. g. 13. maijs 23:45 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 13. maijs 23:17 UTC

Peļņas

Samsung Fire & Marine Insurance 1Q Net Profit Beat FactSet-Compiled Consensus

2026. g. 13. maijs 23:16 UTC

Peļņas

Samsung Fire & Marine Insurance 1Q Net KRW635.22B Vs. Net KRW609.03B >000810.SE

2026. g. 13. maijs 23:15 UTC

Peļņas

Samsung Fire & Marine Insurance 1Q Oper Pft KRW861.13B Vs. Pft KRW792.36B >000810.SE

2026. g. 13. maijs 23:14 UTC

Peļņas

Samsung Fire & Marine Insurance 1Q Rev KRW6.676T Vs. KRW6.106T >000810.SE

2026. g. 13. maijs 23:02 UTC

Tirgus saruna

Peļņas

Cisco Product Demand Climbing Even Without Hyperscalers -- Market Talk

2026. g. 13. maijs 22:59 UTC

Tirgus saruna

Peļņas

Cisco Boosted by Tech Infrastructure Upgrade Cycle -- Market Talk

2026. g. 13. maijs 22:24 UTC

Peļņas

Xero FY U.S. Organic Revenue Growth 30%>XRO.AU

2026. g. 13. maijs 22:23 UTC

Peļņas

Xero FY International Organic Revenue Growth 25%>XRO.AU

2026. g. 13. maijs 22:23 UTC

Peļņas

Xero FY International Revenue Growth 47%>XRO.AU

2026. g. 13. maijs 22:22 UTC

Peļņas

Xero FY Australia, New Zealand Revenue Up 18% on Year >XRO.AU

2026. g. 13. maijs 22:19 UTC

Peļņas

Xero FY Australia, New Zealand Revenue Up 17% in Constant Currency>XRO.AU

2026. g. 13. maijs 22:19 UTC

Peļņas

Xero FY Net Customer Additions 506,000 Vs. 254,000>XRO.AU

2026. g. 13. maijs 22:18 UTC

Peļņas

Xero FY Rule of 40: 48.5% Vs. 44.3%>XRO.AU

2026. g. 13. maijs 22:16 UTC

Peļņas

Xero: Ebitda Guidance Includes NZD55M of Incremental U.S. Brand Spend>XRO.AU

2026. g. 13. maijs 22:15 UTC

Peļņas

Xero Expects FY27 Adjusted Ebitda of NZD860M-NZD920M>XRO.AU

2026. g. 13. maijs 22:15 UTC

Peļņas

Xero Expects FY27 Operating Revenue of NZD3.62B-NZD3.73B>XRO.AU

2026. g. 13. maijs 22:13 UTC

Peļņas

Xero FY Operating Expenses 70.5% of Operating Revenue Vs. 71.8%>XRO.AU

2026. g. 13. maijs 22:12 UTC

Peļņas

Xero FY Free Cash Flow NZD554.0M Vs. NZD506.7M>XRO.AU

2026. g. 13. maijs 22:11 UTC

Peļņas

Xero FY Adjusted Ebitda NZD757.4M Vs. NZD641.8M>XRO.AU

2026. g. 13. maijs 22:11 UTC

Peļņas

Xero FY Ebitda NZD789.5M Vs. NZD638.5M>XRO.AU

2026. g. 13. maijs 22:10 UTC

Peļņas

Xero Did Not Declare a Dividend>XRO.AU

2026. g. 13. maijs 22:10 UTC

Peļņas

Xero FY Rev NZD2.75B Vs. NZD2.10B >XRO.AU

2026. g. 13. maijs 22:09 UTC

Peļņas

Xero FY Net NZD167.4M Vs. Net NZD227.8M >XRO.AU

2026. g. 13. maijs 22:00 UTC

Peļņas

Cisco to Shed Jobs for All-In AI Push -- Update

2026. g. 13. maijs 21:11 UTC

Peļņas

Cisco Earnings and Revenue Beat Estimates on Strong AI Demand. Its Shares Surge. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

CryoPort Inc Prognoze

Cenas mērķis

By TipRanks

4.14% augšup

Prognoze 12 mēnešiem

Vidējais 13.58 USD 4.14%

Augstākais 17 USD

Zemākais 9.5 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CryoPort Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 7 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CryoPort Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

5.615 / N/AAtbalsts un pretestība

Recent bullish events outweigh bearish events.

There is one bullish event.

Noskaņojums

By Acuity

386 / 405 Rangs Rūpniecība

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.